Health & WellnessTech
Gerostate Alpha (YC S18)
A pharmaceutical company dedicated to treating aging and age-related disease
San Francisco,
CA
Investment type:
Equity
(SAFE)
Target raise:
$50,000
- $1,070,000
Minimum investment:
$100
$100
End date:
Aug 10, 2021
Aug 10, 2021
ended
Share
Highlights
- ?? $2.1M raised in initial seed round, at $15M valuation cap
- ?? Team at the forefront of aging research for decades, collectively authoring 200+ papers
- ?? Our platform delivers drug candidates to slow aging at a success rate of 20%
- ?? Funds will be used to test 10-15 of our hits in aging mice
Our Story
Gerostate Alpha is a new pharmaceutical company dedicated to treating aging and age-related disease. Incubating at the Buck Institute for Research on Aging, we develop breakthrough pharmaceuticals through proprietary innovations to mitigate and reduce the effects of aging.
Our Ambition
Phase 2/3 with multiple hits covering different aspects of aging, we will be the leading company revolutionizing medicine